Profound Therapeutics Leverages AI and Ribosome Profiling to Uncover Thousands of Hidden Proteins for Drug Discovery
Rapid Read

Profound Therapeutics Leverages AI and Ribosome Profiling to Uncover Thousands of Hidden Proteins for Drug Discovery

What's Happening? Profound Therapeutics, led by CEO John Lepore, is utilizing a novel approach combining ribosome-level profiling and artificial intelligence to map thousands of previously uncatalogued proteins across over 500 human cell types and tissues. This method challenges the traditional unde
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.